Antibacterial and antiviral resin member
By adjusting the charged charge amount of the resin component and applying O/W emulsion to the substrate surface, combined with non-ionic surfactants, the antibacterial and antiviral properties of the antibacterial and antiviral resin components are improved, and the charged charge in the prior art is solved The problem of insufficient amount has achieved efficient bacterial and virus inactivation effect.
Patent Information
- Application Number
- CN202380032162.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-31
- Filing Date
- 2023-03-30
- Publication Date
- 2024-11-15
AI Technical Summary
The charged charge of existing antibacterial and antiviral resin components is insufficient, resulting in poor contact efficiency with bacteria and viruses, and insufficient antibacterial and antiviral performance.
By adjusting the charged charge amount of the resin component to be 0 μC/m2 or more and less than 7 μC/m2, combined with the coating of O/W emulsion and adhering oil-soluble substances on the surface of the matrix, it is preferable to use a nonionic surfactant to improve the antibacterial and antiviral agent. Contact efficiency.
The inactivation efficiency of antibacterial and antiviral resin components on bacteria and viruses is significantly improved, and bacteria and viruses attached to the surface can be efficiently inactivated in a short period of time.
Smart Images

Figure BDA0005068425470000181 
Figure BDA0005068425470000191
Abstract
Description
Technical Field
[0001] The present invention relates to an antibacterial and antiviral resin composition capable of inactivating attached bacteria and viruses. Background Art
[0002] Due to the COVID-19 pandemic, our lifestyles have changed significantly. Masks and disinfectants have become a necessity in daily life, and general consumers are also becoming more interested in antiviral products, which have been of great concern to medical professionals. Among them, the demand for air purifiers and air conditioners for indoor environment conditioning has increased, and the demand for not only antibacterial performance but also antiviral functions is increasing.
[0003] In order to solve these problems, molded products such as filters and antiviral membranes having antibacterial and antiviral properties have been developed (for example, Patent Documents 1, 2, and 3). Prior art literature Patent Literature
[0004] Patent Document 1: International Publication No. 2011 / 040048 Patent Document 2: Japanese Patent Application Publication No. 2005-007346 Patent document 3: Japanese Patent Application Publication No. 2021-066874. Summary of the invention Problem that the invention aims to solve
[0005] However, the resin materials used in filters are mainly highly waterproof resins (matrix) such as cheap and easy-to-process polypropylene (PP). Previous antibacterial and antiviral resin components that only fixed antibacterial and antiviral agents on the surface of the matrix had poor contact efficiency with viruses and bacteria, and their antibacterial and antiviral properties were insufficient.
[0006] An object of the present invention is to provide an antibacterial and antiviral resin component that can efficiently inactivate bacteria and viruses attached to the surface. Means for solving problems
[0007] The inventors of the present invention have conducted intensive research and found that by making the charge amount of the antibacterial and antiviral resin component 0 μC / m 2 Above and less than 7μC / m 2 , preferably 0μC / m 2 Above and less than 0.7μC / m 2 , can improve the contact efficiency with bacteria and viruses, and can improve the antibacterial and antiviral properties.
[0008] That is, the first invention is an antibacterial and antiviral resin component, characterized in that it comprises a matrix formed of a resin and an antibacterial and antiviral agent contained in the matrix, wherein the charge amount of the antibacterial and antiviral resin component is 0 μC / m 2 Above and less than 7μC / m 2 .
[0009] Furthermore, a second invention is an antibacterial and antiviral resin component, characterized in that the surface of the substrate in the first invention is coated with an O / W emulsion.
[0010] Moreover, the third invention is an antibacterial and antiviral resin component, characterized in that an oil-soluble substance is attached to the surface of the substrate in the first invention.
[0011] Furthermore, a fourth invention is an antibacterial and antiviral resin component, characterized in that the oil-soluble substance in the third invention is selected from at least one of liquid paraffin, mineral oil and fatty acid ester.
[0012] Furthermore, a fifth invention is an antibacterial and antiviral resin member, characterized in that a surfactant is attached to the surface of the substrate in the third invention or the fourth invention.
[0013] Moreover, the sixth invention is an antibacterial and antiviral resin component, characterized in that the surfactant in the fifth invention is a nonionic surfactant.
[0014] In addition, the seventh invention is an antibacterial and antiviral resin component, characterized in that the nonionic surfactant in the sixth invention is one or more selected from polyoxyalkyl ethers, polyoxyethylene alkyl ethers and polyoxypropylene alkyl ethers. Effects of the Invention
[0015] According to the present invention, it is possible to provide an antibacterial and antiviral resin member capable of efficiently inactivating bacteria and viruses attached to the surface. DETAILED DESCRIPTION
[0016] Hereinafter, one embodiment of the present invention will be described.
[0017] The antibacterial and antiviral resin component of the present embodiment includes a matrix formed of a resin and an antibacterial and antiviral agent contained in the matrix. The charge amount of the antibacterial and antiviral resin component is 0 μC / m 2 Above and less than 7μC / m 2It should be noted that, in this specification, the electric charge of the antibacterial and antiviral resin component refers to the electric charge measured by method C (frictional charge determination method) in accordance with JIS L 1094:2020 "Test method for chargeability of woven and knitted fabrics" under the conditions of temperature 20°C±2°C and relative humidity 40%±2% using an acrylic cloth formed of acrylic fibers as a friction cloth.
[0018] The base constituting the antibacterial and antiviral resin member of the present embodiment is a material for fixing an antibacterial and antiviral agent described later, and is formed of a resin.
[0019] Examples of the resin that can be used as a material for the matrix include polyethylene resin, polypropylene resin, polystyrene resin, ABS resin, AS resin, AES resin, EVA resin, polymethylpentene resin, polyvinyl chloride resin, polyvinylidene chloride resin, polymethyl acrylate resin, polyvinyl acetate resin, polyamide resin, polyimide resin, polycarbonate resin, polyethylene terephthalate resin, polybutylene terephthalate resin, polyacetal resin, polyarylate resin, polysulfone resin and other thermoplastic resins, silicone resin, styrene elastomers such as polystyrene elastomer, olefin elastomers such as polyethylene elastomer and polypropylene elastomer, polyurethane elastomers such as polyurethane elastomer, vinyl chloride elastomers, polyester elastomers, nylon elastomers and other thermoplastic elastomers.
[0020] The resin constituting the matrix may be one kind or two or more kinds.
[0021] The shape and form of the substrate constituting the antibacterial and antiviral resin member of this embodiment are not particularly limited, and may be in the form of a sheet such as a woven fabric, knitted fabric, nonwoven fabric, sheet, or film, or may be a molded body formed into a predetermined shape.
[0022] The antibacterial and antiviral agent contained in the matrix is a substance that exhibits antibacterial and antiviral properties, and known organic and inorganic substances can be used.
[0023] As organic antibacterial and antiviral agents, there can be mentioned synthetic organic antibacterial and antiviral agents such as thiazole, isothiazole, imidazole, pyridine, triazine, aldehyde, phenol, biguanide, nitrile, halogen, aniline, disulfide, thiocarbamate, silicone quaternary ammonium salt, quaternary ammonium salt, amino acid, organometallic, alcohol, carboxylic acid, and ester, and natural organic antibacterial and antiviral agents such as cypress thiol and chitosan.
[0024] As the antibacterial and antiviral agent of inorganic system, silver, copper, zinc, platinum, zinc compound, silver compound, copper compound, metal oxide catalyst supported with metal or metal oxide, zeolite, activated carbon, mesoporous silica, silica gel etc. that have been ion-exchanged with metal ions can be cited.It should be noted that the shape of the antibacterial and antiviral agent of inorganic system is not particularly limited, and is preferably microparticles from the viewpoint of further improving antibacterial and antiviral performance.The particle size of microparticles is not particularly limited, and from the viewpoint of further improving antibacterial and antiviral performance, the volume average particle size is preferably more than 1.0nm and less than 500nm.Here, the volume average particle size can be measured by, for example, laser Doppler method (dynamic electrophoretic light scattering method), and can use, for example, Zeta potential particle size measurement system (made by Otsuka Electronics) in the measurement.
[0025] Among the aforementioned antibacterial and antiviral agents, inorganic antibacterial and antiviral agents are preferably used, copper compounds are more preferably used, and monovalent copper compounds are particularly preferably used, from the viewpoint of further improving the antibacterial and antiviral properties. Inorganic antibacterial and antiviral agents are not related to the type of genome, the presence or absence of an envelope, etc., and can reduce the infectivity of various viruses or inactivate various viruses.
[0026] Examples of viruses that can be inactivated by the antibacterial and antiviral resin component of the present embodiment include rhinovirus, poliovirus, foot-and-mouth disease virus, rotavirus, norovirus, enterovirus, hepatovirus, astrovirus, zaruvirus, hepatitis E virus, influenza A / B / C virus, parainfluenza virus, mumps virus (epidemic mumps), measles virus, human metapneumovirus, RS virus, Nipah virus, Hendra virus, yellow fever virus, dengue virus, Japanese encephalitis virus, West Nile virus, hepatitis B / C virus, eastern and western equine encephalitis virus, Agnone-Nyanong virus, rubella virus, Las Vegas virus, and SARS-CoV-2 virus. Arena virus, Junin virus, Machupo virus, Guanarito virus, Sabia virus, Crimean-Congo hemorrhagic fever virus, sand fly fever, Hantavirus, Sin Noble virus, rabies virus, Ebola virus, Marburg virus, bat lyssa virus, human T-cell leukemia virus, human immunodeficiency virus, human coronavirus, SARS coronavirus, human parvovirus, polyomavirus, human papillomavirus, adenovirus, herpes virus, varicella, herpes zoster virus, Epstein-Barr virus, cytomegalovirus, smallpox virus, monkeypox virus, cowpox virus, Morasipox virus, parapoxvirus, Zika virus, new coronavirus, etc.
[0027] As bacteria that can be inactivated by the antibacterial and antiviral resin component of this embodiment, various bacteria can be listed, regardless of their properties such as Gram-positive / negative, aerobic / anaerobic, etc. Specifically, for example, Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, Pneumococcus, influenza bacteria, pertussis bacteria, enteritis bacteria, Klebsiella pneumoniae, Pseudomonas aeruginosa, Vibrio, Salmonella, cholera bacteria, Shigella dysenteriae, anthrax bacteria, Mycobacterium tuberculosis, Clostridium botulinum, tetanus bacteria, and Streptococcus.
[0028] In addition, the antibacterial and antiviral agent contained in the matrix may be one substance or two or more substances. For example, at least two substances of a substance that only exerts antibacterial properties and a substance that only exerts antiviral properties may be used as antibacterial and antiviral agents, or at least one substance that exerts both antibacterial and antiviral properties may be used. As an antibacterial and antiviral agent that exerts both antibacterial and antiviral properties, for example, a monovalent copper compound may be exemplified.
[0029] The form of the antibacterial and antiviral agent contained in the matrix is not particularly limited. The antibacterial and antiviral agent may be dispersed in the matrix, at least a portion of the antibacterial and antiviral agent dispersed in the matrix may be exposed from the surface of the matrix, or the antibacterial and antiviral agent may be fixed to the surface of the matrix. From the perspective of improving the contact efficiency between the antibacterial and antiviral agent and bacteria and viruses, the antibacterial and antiviral agent is preferably fixed to the surface of the matrix.
[0030] The content of the antibacterial and antiviral agent can be appropriately set according to the desired antibacterial and antiviral performances, for example, it can be set to 0.1 mass % or more and less than 80 mass % relative to 100 mass % of the antibacterial and antiviral resin part, preferably 0.1 mass % or more and 15 mass % or less.
[0031] In the matrix, in addition to the above-mentioned antibacterial and antiviral agents, other components (hereinafter, also referred to as "other components") other than the antibacterial and antiviral agents may also be contained. As other components, plasticizers, desiccants, curing agents, anti-skinning agents, flattening agents, anti-dripping agents, mildew inhibitors, ultraviolet absorbers, heat ray absorbers, lubricants, surfactants, thickeners, viscosity regulators, stabilizers, drying regulators, pigments, dispersants, mildew-proof compositions, antiallergic compositions, catalysts, antireflective materials, materials with heat insulation properties may be cited. Other components may also include more than two kinds. The form of the other components contained in the matrix is not particularly limited, and may be dispersed in the interior of the matrix, or a part of the other components dispersed in the interior of the matrix may be exposed from the surface of the matrix, or may be fixed to the surface of the matrix.
[0032] For the antibacterial and antiviral resin component of this embodiment, the charge amount (hereinafter also referred to as "charge amount") measured by the C method (friction charge amount determination method) according to JIS L 1094:2020 "Test method for chargeability of fabrics and woven fabrics" under the conditions of temperature 20°C ± 2°C and humidity 40% ± 2% using acrylic cloth composed of acrylic fibers as the friction cloth is 0 μC / m 2 Above and less than 7μC / m 2 . The charge is 7μC / m 2 In the above case, the contact efficiency with bacteria and viruses attached to the surface is reduced, and bacteria and viruses cannot be inactivated efficiently. The charge amount of the antibacterial and antiviral resin component is 0 μC / m 2 Above and less than 7μC / m 2 However, from the viewpoint of further improving the antibacterial and antiviral properties, 0 μC / m 2 Above and less than 0.7μC / m 2 .
[0033] The amount of charge on the antibacterial and antiviral resin component varies depending on the type and mixing ratio of the material constituting the matrix. Therefore, the charge can be set to 0 μC / m by adjusting the composition of the resin constituting the matrix. 2 Above and less than 7μC / m 2 On the other hand, the charge amount of the antibacterial and antiviral resin component can also be adjusted by coating the O / W emulsion on the substrate surface. The charge amount of the antibacterial and antiviral resin component depends on the composition and coating amount of the O / W emulsion coated on the substrate surface. Therefore, by adjusting the composition and coating amount of the O / W emulsion, it can be set to 0 μC / m 2 Above and less than 7μC / m 2 . When the O / W emulsion is applied on the surface of the substrate to adjust the amount of charge, the composition of the material constituting the substrate is less likely to be restricted than when the amount of charge is adjusted by the composition of the resin constituting the substrate, and the antibacterial and antiviral resin components can be easily applied to more uses. In addition, when the O / W emulsion is applied on the surface of the substrate to adjust the amount of charge, it is easier to adjust the amount of solid components (non-volatile components) on the surface of the substrate by the emulsion concentration than when a substance other than the O / W emulsion is attached to the surface of the substrate to adjust the amount of charge.
[0034] Here, emulsion refers to a system in which one of two mutually immiscible substances (oil-soluble substance and water-soluble substance) is dispersed as fine droplets in the liquid phase of the other, and there are O / W emulsions (oil-in-water dispersion type emulsions) in which droplets composed of oil-soluble substances are dispersed in water-soluble substances and W / O emulsions (water-in-oil dispersion type emulsions) in which droplets of water-soluble substances are dispersed in oil-soluble substances. In the present embodiment, in order to adjust the amount of electric charge, O / W emulsions are preferably used among these emulsions.
[0035] The O / W emulsion contains at least an oil-soluble substance for forming droplets and a water-soluble substance for dispersing droplets. The oil-soluble substance can be any liquid, paste-like or solid oil-soluble substance at room temperature, and is not particularly limited. For example, fatty acids such as isostearic acid, isopalmitic acid, oleic acid, palmitoleic acid, linoleic acid, and ricinoleic acid, lanolin, lanolin alcohol, hydrogenated lanolin alcohol and other lanolin derivatives, cetyl alcohol, hexyldecanol, isostearyl alcohol, stearyl alcohol, octyldodecanol, oleyl alcohol, cetearyl alcohol, behenyl alcohol and other higher alcohols, cholesterol derivatives and phytosterol derivatives and other fatty acid esters and fatty acid oligomer esters derived from animal and vegetable oils, paraffin, mineral oil, fatty acid esters (PEO), etc., and one or more of them can be used. The water-soluble substance can be any liquid at room temperature, and is not particularly limited. For example, water can be used. Since the electric charge of the antibacterial and antiviral resin component is easy to become 0μC / m 2 Above and less than 7μC / m 2 Therefore, as the oil-soluble substance, it is preferred to use one or more selected from liquid paraffin, mineral oil and fatty acid ester (PEO), and as the water-soluble substance, it is preferred to use water.
[0036] It should be noted that the carbon number of the fatty acid ester as one of the oil-soluble substances is not limited, and it can be a saturated fatty acid ester or an unsaturated fatty acid ester. From the viewpoint of more efficiently inactivating bacteria and viruses, the fatty acid ester that can be used as the oil-soluble substance is preferably a liquid fatty acid ester having 15 to 50 carbon atoms.
[0037] The content of the oil-soluble substance in the O / W emulsion is such that the charge amount of the antibacterial and antiviral resin component becomes 0 μC / m 2 Above and less than 7μC / m 2 The amount may be appropriately adjusted, and for example, may be 3% by mass or more and 15% by mass or less relative to 100% by mass of the coating liquid (100% by mass of the O / W emulsion).
[0038] The O / W emulsion only needs to contain at least an oil-soluble substance and a water-soluble substance, but preferably further contains a surfactant in order to stably disperse the oil droplets in water. The surfactant is not particularly limited, and both anionic surfactants and nonionic surfactants can be used.
[0039] As anionic surfactants, anionic surfactants having carboxylic acid, sulfonic acid or phosphoric acid structures as hydrophilic groups can be used. In addition, as carboxylic acid surfactants, for example, fatty acid salts and bile salts as the main components of soap can be exemplified. In addition, as sulfonic acid surfactants, linear alkylbenzene sodium sulfonate and sodium lauryl sulfate, which are used in large quantities in synthetic detergents, can be cited. More specifically, carboxylates such as fatty acid sodium soap, potassium oleate soap, alkyl ether carboxylates, sodium lauryl sulfate, higher alcohol sodium sulfate, triethanolamine lauryl sulfate, polyoxyethylene lauryl ether sodium sulfate, polyoxyethylene alkyl ether sodium sulfate, sodium dodecylbenzene sulfonate, sodium alkylnaphthalene sulfonate, sodium alkyl diphenyl ether disulfonate, sodium alkane sulfonate, sulfonates such as sodium salts of aromatic sulfonic acid formaldehyde condensates, alkyl phosphate potassium salts, sodium hexametaphosphate, dialkyl sulfosuccinic acid, etc. can be cited. These surfactants can be used alone or in combination.
[0040] In addition, as nonionic surfactants, alkylphenol ethylene oxide adducts and higher alcohol ethylene oxide adducts, polyoxyethylene fatty acid esters, fatty acid ethylene oxide adducts and polyethylene glycol fatty acid esters, higher alkylamine ethylene oxide adducts and fatty acid amide ethylene oxide adducts, polyoxyethylene alkylamines and polyoxyethylene fatty acid amides, polypropylene glycol ethylene oxide adducts, nonionic surfactants glycerol and fatty acid esters of pentaerythritol, sorbitol and sorbitan fatty acid esters, sucrose fatty acid esters, alkyl polyglycoside fatty acids, alkanolamides, etc. These surfactants can be used alone or in combination.
[0041] Among the above-mentioned surfactants, nonionic surfactants form large micelles compared to anionic surfactants and can hold a large amount of oil-soluble substances, so nonionic surfactants are preferably used. In particular, among the nonionic surfactants, one or more selected from polyoxyalkyl ethers, polyoxyethylene alkyl ethers and polyoxypropylene alkyl ethers are particularly preferred.
[0042] The content of the surfactant in the O / W emulsion is based on the charge of the antibacterial and antiviral resin component being 0 μC / m 2 Above and less than 7μC / m 2 The amount may be appropriately adjusted without particular limitation, and may be, for example, 0.025 to 5% by mass relative to 100% by mass of the coating liquid (100% by mass of the O / W emulsion).
[0043] By applying the O / W emulsion to the surface of the substrate, the non-volatile components contained in the coating liquid adhere to the surface of the substrate, and the charge amount of the antibacterial and antiviral resin component is adjusted by the non-volatile components. It should be noted that the non-volatile components can be listed as oil-soluble substances and surfactants in the components of the above-mentioned coating liquid. The content of the non-volatile components in the O / W emulsion is as long as the charge amount when using acrylic acid as the friction cloth of the antibacterial and antiviral resin component is 0μC / m 2 Above and less than 7μC / m 2 The amount may be appropriately adjusted without particular limitation, and may be, for example, 0.4 to 30% by mass relative to 100% by mass of the coating liquid (100% by mass of the O / W emulsion).
[0044] In the antibacterial and antiviral resin component of the present embodiment obtained by applying an O / W emulsion to a substrate, the non-volatile components contained in the O / W emulsion adhere to the surface of the substrate and remain. Therefore, for example, in the antibacterial and antiviral resin component of the present embodiment manufactured by applying an O / W emulsion containing a water-soluble substance and an oil-soluble substance to a substrate, the oil-soluble substance remains on the surface of the substrate as a non-volatile component of the O / W emulsion. In addition, for example, in the antibacterial and antiviral resin component of the present embodiment manufactured by applying an O / W emulsion containing a water-soluble substance, an oil-soluble substance and a surfactant to a substrate, a mixture containing an oil-soluble substance and a surfactant remains (adheres) on the surface of the substrate as a non-volatile component of the O / W emulsion.
[0045] In the antibacterial and antiviral resin component of the present embodiment manufactured by applying the O / W emulsion to the substrate, the amount of non-volatile components of the O / W emulsion attached to the substrate (the content of non-volatile components in the antibacterial and antiviral resin component) is set to 0 μC / m 2 Above and less than 7μC / m 2 The method can be appropriately adjusted, for example, relative to 100% by mass of the antibacterial and antiviral resin part, it can be set to 0.1% by mass or more and 20% by mass or less. From the viewpoint of more effectively inactivating bacteria and viruses, the amount of non-volatile components of the O / W emulsion attached to the substrate (the content of non-volatile components in the antibacterial and antiviral resin part) is preferably 0.3% by mass or more and 12% by mass or less relative to 100% by mass of the antibacterial and antiviral resin part. It should be noted that the amount of non-volatile components attached to the substrate refers to the total amount of non-volatile components attached to the O / W emulsion when there are more than two non-volatile components, and refers to the amount of non-volatile components attached to the substrate when there are only one non-volatile component in the O / W emulsion.
[0046] When a surfactant and an oil-soluble substance (including a mixture of a surfactant and an oil-soluble substance) are attached to a substrate as non-volatile components of an O / W emulsion, the mixing ratio of the surfactant and the oil-soluble substance in the non-volatile component can be, for example, 0.1:100 to 20:100 (surfactant: oil-soluble substance) in terms of mass ratio. From the viewpoint of more efficiently inactivating bacteria and viruses, the mass ratio is preferably 0.5:100 to 10:100 (surfactant: oil-soluble substance).
[0047] Next, a method for producing the antibacterial and antiviral resin member according to the present embodiment will be described.
[0048] When the charge amount of the antibacterial and antiviral resin component is adjusted by the type and mixing ratio of the material constituting the base, the charge amount of the antibacterial and antiviral resin component is adjusted to 0 μC / m 2 Above and less than 7μC / m 2 The antibacterial and antiviral agent is contained in the matrix, and the antibacterial and antiviral resin component of this embodiment can be manufactured.
[0049] The method of containing the antibacterial and antiviral agent in the matrix can be appropriately set according to the form of the antibacterial and antiviral agent, and is not particularly limited. For example, when the antibacterial and antiviral agent is dispersed inside the matrix, the antibacterial and antiviral resin component is charged with a charge amount of 0 μC / m 2 Above and less than 7μC / m 2 The antibacterial and antiviral resin component of the present embodiment can be manufactured by adding an antibacterial and antiviral agent to the raw material of the base material pre-adjusted in a manner and mixing, and then molding into a predetermined shape. In addition, for example, when the antibacterial and antiviral agent is fixed to the surface of the base, the antibacterial and antiviral agent is fixed to the surface of the antibacterial and antiviral resin component pre-adjusted to have a charged amount of 0 μC / m 2 Above and less than 7μC / m 2 The antibacterial and antiviral resin component of this embodiment can be manufactured by fixing the antibacterial and antiviral agent to the substrate. There is no particular limitation on the method of fixing the antibacterial and antiviral agent to the substrate, and a conventionally known method can be used.
[0050] In addition, when the charge amount of the antibacterial and antiviral resin component is adjusted by coating the O / W emulsion on the substrate surface, the charge amount of the antibacterial and antiviral resin component is adjusted to 0 μC / m by coating the substrate containing the antibacterial and antiviral agent. 2 Above and less than 7μC / m 2 The antibacterial and antiviral resin component of this embodiment can be manufactured by preparing an O / W emulsion and drying it.
[0051] The method for coating the O / W emulsion on the substrate surface is not particularly limited, and conventionally known methods can be used. For example, methods such as dipping, spraying, roller coating, rod coating, spin coating, gravure printing, offset printing, screen printing, and inkjet printing can be used.
[0052] Next, an example of a method for producing the antibacterial and antiviral resin member of the present embodiment by applying an O / W emulsion on the surface of a resin (substrate) to which copper compound particles (antibacterial and antiviral agent) are fixed will be described in detail.
[0053] First, the copper compound particles are pulverized into nano-sized particles by a jet mill, a hammer mill, a ball mill, a vibration mill, a bead mill, etc. There are no particular restrictions on the pulverization method, and both dry and wet methods can be used.
[0054] Next, the pulverized copper compound particles are dispersed in a dispersion medium such as water, methanol, ethanol, MEK (methyl ethyl ketone), acetone, xylene, toluene, etc. At this time, when other materials, such as reinforcing materials and functional materials are mixed, these materials are added. Next, a dispersant such as a surfactant is added as needed, and a device such as a bead mill, a ball mill, a sand mill, a roller mill, a vibration mill, a homogenizer, etc. is used for dispersion and crushing, and then a silane monomer is added to prepare a slurry in which copper compound particles are dispersed.
[0055] Utilize the methods such as impregnation, spraying, roller coating, rod coating, spin coating, gravure printing, offset printing, screen printing, inkjet printing to apply the slurry made as above to the resin as matrix. At this time, as required, remove the solvent (dispersion medium) by heating and drying etc. Then, by graft polymerization based on reheating, graft polymerization based on radiation irradiation such as infrared, ultraviolet, electron beam, gamma ray, the functional group on the matrix surface is chemically bonded to the silane monomer, thus obtaining the resin (containing the matrix of antibacterial and antiviral agent) fixed with copper compound particles.
[0056] Furthermore, the surface of the substrate thus obtained is coated with an antibacterial and antiviral resin member whose charge amount is adjusted to 0 μC / m 2 Above and less than 7μC / m 2 The O / W emulsion is prepared and dried. The coating method can be dipped, sprayed, rolled, rod coated, spin coated, gravure, offset, screen printed, ink jet printed, etc. as described above. In addition, the drying method can be any method known in the past as long as it is a method of removing volatile components from the O / W emulsion applied to the surface of the substrate. By these operations, the antibacterial and antiviral resin component of the present embodiment can be obtained.
[0057] In addition, an example of a method for producing the antibacterial and antiviral resin member of the present embodiment by applying an O / W emulsion on the surface of a resin (matrix) in which copper compound particles (antibacterial and antiviral agent) are dispersed will be described in detail.
[0058] First, master batch particles in which copper compound particles as an antibacterial and antiviral agent are mixed (dispersed) are prepared. The master batch particles are prepared, for example, as follows.
[0059] The crushed copper compound particles are mixed with a known dispersant to generate an antibacterial and antiviral agent whose surface is coated with a dispersant, and then the antibacterial and antiviral agent is mixed with resin particles, and the antibacterial and antiviral agent is dispersed in the interior of the resin particles by using a mixing extruder. Alternatively, the crushed copper compound particles and the dispersant are mixed with resin pellets, and a mixing extruder is used to attract the dispersant around the copper compound fine particles during mixing, resulting in an antibacterial and antiviral agent in which the copper compound fine particles are covered with a dispersant, and the antibacterial and antiviral agent is dispersed in the resin pellets. After the mixture is cooled, the resin containing the antibacterial and antiviral agent is finely cut using a granulator to obtain masterbatch particles mixed (dispersed) with the antibacterial and antiviral agent. It should be noted that those skilled in the art can appropriately set the ratio (concentration) of the antibacterial and antiviral agent during the manufacture of the masterbatch particles.
[0060] The obtained masterbatch pellets are melt-kneaded and molded with a resin using a molding machine to obtain a resin (matrix) in which an antibacterial and antiviral agent is dispersed. For molding, injection molding, Bromide molding, and other methods can be used.
[0061] It should be noted that the antibacterial and antiviral resin component of the present embodiment, in addition to the molded product, also includes forms such as sheet, film, fiber, cloth, mesh (net structure), honeycomb, non-woven fabric, etc., and can be manufactured in various forms (shape, size, etc.) that meet the purpose of use. In the case where the antibacterial and antiviral resin component is made into a sheet or film, the resin dispersed with the antibacterial and antiviral agent can be molded by a T-mold method, an inflation method, etc. In addition, in the case where the antibacterial and antiviral resin component is made into a fiber, the resin dispersed with the antibacterial and antiviral agent can be molded by a melt spinning method, etc., or it can be made into a shaped yarn, a core sheath yarn, etc. In particular, when the core sheath yarn is made, by using a resin containing an antibacterial and antiviral agent in the sheath portion, it is possible to exert antibacterial and antiviral properties while reducing the amount of the antibacterial and antiviral agent used, so it is preferred. In addition, in the case where the antibacterial and antiviral resin component is made into a non-woven fabric, the resin dispersed with the antibacterial and antiviral agent can be molded by existing methods such as a spunbond method.
[0062] When the matrix contains other components in addition to the antibacterial and antiviral agent, the matrix may contain other components together with the antibacterial and antiviral agent.
[0063] The surface of the substrate (resin in which the antibacterial and antiviral agent is dispersed) thus obtained is coated with an antibacterial and antiviral resin member which has been adjusted in advance to have a charge amount of 0 μC / m 2 Above and less than 7μC / m 2 The O / W emulsion is applied to the substrate surface and dried. The coating method is the same as above, and methods such as dipping, spraying, roller coating, rod coating, spin coating, gravure printing, offset printing, screen printing, and inkjet printing can be used. In addition, the drying method can be any method known in the past as long as it is a method for removing volatile components from the O / W emulsion applied to the substrate surface. Through these operations, the antibacterial and antiviral resin component of the present embodiment can be obtained.
[0064] The antibacterial and antiviral resin parts of the present embodiment obtained by the above-mentioned manufacturing method can of course be used as basic fiber structures such as fabrics, woven fabrics, and non-woven fabrics, and can also be used as sheet products for constituting clothes, bedding, sleeping materials, masks, handkerchiefs, towels, carpets, curtains, outer wall materials, building materials, interior materials, etc., filters for air purifiers, air conditioners, ventilation fans, electric vacuum cleaners, electric fans, air conditioners, vehicles, etc., agricultural materials such as protective clothing, protective nets, insect-proof nets, chicken coop nets, house membranes, tunnel chamber membranes, fin materials for air conditioners, pallets for plant factories, etc., panels, window frames, doors, blinds, ceilings, floors, windows, etc., building materials, interior materials, outer wall materials, etc.
[0065] According to the antibacterial and antiviral resin member of the present embodiment described above, bacteria and viruses adhering to the surface can be efficiently inactivated. Example
[0066] Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples. <Production of Cuprous Iodide-Containing Fiber>
[0067] The polyethylene masterbatch particles containing copper (I) iodide (CuI) as an antibacterial and antiviral agent and polyethylene resin are melt-mixed with polypropylene resin so that the masterbatch particles are 10wt%, and a mixture containing 1% by mass of copper (I) iodide is obtained. The obtained mixture is melted using a melt extruder provided in a melt spinning device, ejected from a spinneret provided in the melt spinning device, cooled in a water tank and pulled at a specified speed, thereby obtaining a copper (I) iodide-containing fiber. The fiber diameter of the obtained copper iodide-containing fiber is 150μm, and the volume average particle size of the cuprous iodide is 350nm.
[0068] (Example 1) The copper (I) iodide-containing fiber obtained above was used to weave a fabric (plain weave; 60 mesh) using a rapier loom (manufactured by Drunier). During weaving, a cloth impregnated with an O / W emulsion (MelyW, Maru Ryo Oil Chemical Industry Co., Ltd.) containing 1.3% by mass of a nonionic surfactant (polyoxyethylene alkyl ether) and 26% by mass of mineral oil was placed, and the O / W emulsion was applied to the fiber and woven to obtain the antibacterial and antiviral resin composition (fabric) of Example 1. In the antibacterial and antiviral resin composition of Example 1, the content (adhesion) of the non-volatile component of the O / W emulsion was 7.1% by mass relative to 100% by mass of the antibacterial and antiviral fiber.
[0069] (Example 2) The copper (I) iodide-containing fiber obtained above was used to weave a raschel knit (28 mesh) using a raschel warp knitting machine (manufactured by Karl Mayer). During weaving, the fiber was passed through a roller impregnated with an O / W emulsion (Merry W, Maru Ryo Oil Chemical Industry (Strain) Merry W) containing 2.0 mass % of a nonionic surfactant (polyoxyethylene alkyl ether) and 20 mass % of mineral oil, and the O / W emulsion was applied to the fiber and woven to obtain the antibacterial and antiviral resin composition (woven fabric) of Example 2. In the antibacterial and antiviral resin composition of Example 2, the content (adhesion) of the non-volatile component of the O / W emulsion was 10.0 mass % relative to 100 mass % of the antibacterial and antiviral fiber.
[0070] (Example 3) The copper (I) iodide-containing fiber obtained above was used to weave a fabric (plain weave; 60 mesh) using a rapier loom (manufactured by Drunier). During weaving, a cloth impregnated with an O / W emulsion (non-volatile component concentration 10.0 w / wt%; MelyW, Maru Ryo Chemical Industry Co., Ltd.) containing 0.2% by mass of a nonionic surfactant (polyoxyethylene alkyl ether) and 9.5% by mass of mineral oil was placed, and the O / W emulsion was applied to the fiber and woven to obtain the antibacterial and antiviral resin composition (fabric) of Example 3. In the antibacterial and antiviral resin composition of Example 3, the content (adhesion amount) of the non-volatile component of the O / W emulsion was 1.4% by mass relative to 100% by mass of the antibacterial and antiviral fiber.
[0071] (Example 4) The copper (I) iodide-containing fiber obtained above was used to weave a fabric (plain weave; 60 mesh) using a rapier loom (manufactured by Drunier). During weaving, a cloth impregnated with an O / W emulsion (non-volatile component concentration 5w / wt%; MelyW, Maru Ryo Chemical Industry Co., Ltd.) containing 0.04% by mass of a nonionic surfactant (polyoxyethylene alkyl ether) and 4.9% by mass of mineral oil was placed, and the O / W emulsion was applied to the fiber and woven to obtain the antibacterial and antiviral resin composition (fabric) of Example 4. In the antibacterial and antiviral resin composition of Example 4, the content (adhesion amount) of the non-volatile component of the O / W emulsion was 0.4% by mass relative to 100% by mass of the antibacterial and antiviral fiber.
[0072] (Comparative Example 1) The antibacterial and antiviral resin composition (fabric) of Comparative Example 1 was obtained by the same method as in Example 1 (i.e., without applying the O / W emulsion to the copper (I) iodide-containing fiber, except that the cloth impregnated with the O / W emulsion (Mely W, Maru Ryo Oil Chemical Industry Co., Ltd.) was not placed for weaving.
[0073] (Comparative Example 2) The antibacterial and antiviral resin composition (woven fabric) of Comparative Example 2 was obtained by the same method as in Example 2 (i.e., the same method as in Example 2) except that the fiber was not passed through a roller impregnated with an O / W emulsion (Mely W, Maru Ryo Oil Chemical Industry Co., Ltd.).
[0074] (Comparative Example 3) After spinning fibers using polyethylene masterbatch pellets that do not contain copper (I) iodide (CuI) as an antibacterial and antiviral agent, the fibers were woven in the same manner as in Example 1 to obtain a resin composition (fabric) of Comparative Example 3. In the resin composition of Comparative Example 3, the content of nonvolatile components remaining on the surface of the fabric was 7.1% by mass relative to 100% by mass of the fibers.
[0075] <Measurement of the amount of electric charge> The charge amount of each sample of Examples 1 to 4 and Comparative Examples 1 to 3 was measured by the C method (friction charge amount measurement method) according to JIS L 1094 "Test methods for chargeability of fabrics and knitted fabrics", and the charge amount was measured under the conditions of temperature 20±2°C and humidity 40%±2%, using acrylic cloth containing acrylic fiber as friction cloth. The results are shown in Table 1.
[0076] <Determination of antiviral activity> The antiviral properties of each sample of Example 1 to Example 4 and Comparative Example 1 to Comparative Example 3 were determined using influenza virus according to JIS L 1922 "plaque assay". The results are shown in Table 1. In addition, the standard cloth used as a control was a test-attached white cotton cloth (Canequim No. 3) according to JIS L 0803. In addition, the time (2 hours and 24 hours) shown in Table 1 below is the time elapsed from the start of contact between the antibacterial and antiviral resin composition and the virus.
[0077] [Table 1]
[0078] It can be confirmed from the above results that for Examples 1 to 4 coated with O / W emulsion on the surface, due to the small amount of electric charge, it is possible to efficiently contact with the virus, and a high antiviral property below the detection limit is exerted in a short time of 2 hours, but for Comparative Examples 1 and 2 with high electric charge, although containing antibacterial and antiviral agents, it takes 24 hours to reach below the detection limit. In addition, in Comparative Example 3 without antibacterial and antiviral agents, no antiviral effect was observed. It can be confirmed from the above results that by using the antibacterial and antiviral resin composition of the present embodiment, the virus can be efficiently inactivated.
[0079] <Determination of antibacterial properties> The antibacterial properties of each fiber of Examples 1 to 4 and Comparative Examples 1 to 3 were measured using Staphylococcus aureus in accordance with JIS L 1902. The results are shown in Table 2. In addition, the standard cloth used as a control was a test-attached white cotton cloth (Canequim No. 3) in accordance with JIS L 0803. In addition, the time (2 hours and 24 hours) shown in Table 2 below is the time elapsed from the start of contact between the antibacterial and antiviral resin composition and the bacteria.
[0080] [Table 2]
[0081] From the above results, it can be confirmed that for Examples 1 to 4 coated with O / W emulsion on the surface, due to the small amount of electric charge, it is possible to efficiently contact Staphylococcus aureus, and a high antibacterial property below the detection limit is exerted in a short time of 2 hours, but for Comparative Examples 1 and 2 with high electric charge, although containing antibacterial and antiviral agents, it takes 24 hours to reach below the detection limit. In addition, no antibacterial effect was observed in Comparative Example 3 without an antibacterial and antiviral agent. From the above results, it can be confirmed that by using the antibacterial and antiviral resin composition of the present embodiment, viruses and bacteria can be efficiently inactivated.
Claims
1. An antibacterial and antiviral resin component, characterized in that: The invention comprises a matrix formed of a resin and an antibacterial and antiviral agent contained in the matrix. The antibacterial and antiviral resin component has a charge amount of 0 μC / m 2 Above and less than 7μC / m 2 .
2. The antibacterial and antiviral resin component according to claim 1, characterized in that: The surface of the substrate is coated with an O / W emulsion.
3. The antibacterial and antiviral resin component according to claim 1, characterized in that: An oil-soluble substance is attached to the surface of the substrate.
4. The antibacterial and antiviral resin component according to claim 3, characterized in that: The oil-soluble substance is selected from at least one of liquid paraffin, mineral oil and fatty acid ester.
5. The antibacterial and antiviral resin component according to claim 3 or 4, characterized in that: A surfactant is attached to the surface of the substrate.
6. The antibacterial and antiviral resin component according to claim 5, characterized in that: The surfactant is a nonionic surfactant.
7. The antibacterial and antiviral resin component according to claim 6, characterized in that: The nonionic surfactant is selected from at least one of polyoxyalkyl ethers, polyoxyethylene alkyl ethers and polyoxypropylene alkyl ethers.
